ReviewJournal of muscle research and cell motility2025

Progress and prospects in antisense oligonucleotide-mediated exon skipping therapies for Duchenne muscular dystrophy.

Katarzyna Chwalenia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.